LONP1

LONP1 — Lon Peptidase 1

Introduction

Lonp1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@tatsuta2006]
<table> [@ngo2013]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Lon Peptidase 1, Mitochondrial</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>LONP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Lon Peptidase 1, Mitochondrial</td></tr>
<tr><td><strong>Chromosome</strong></td><td>19p13.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[93624](https://www.ncbi.nlm.nih.gov/gene/93624)</td></tr>
<tr><td><strong>OMIM</strong></td><td>607440</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000125726</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P36776](https://www.uniprot.org/uniprot/P36776)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Mitochondrial Disorders</td></tr>
</table>
</div>

Overview

This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.

Function

LONP1 — Lon Peptidase 1

Introduction

Lonp1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@tatsuta2006]
<table> [@ngo2013]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Lon Peptidase 1, Mitochondrial</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>LONP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Lon Peptidase 1, Mitochondrial</td></tr>
<tr><td><strong>Chromosome</strong></td><td>19p13.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[93624](https://www.ncbi.nlm.nih.gov/gene/93624)</td></tr>
<tr><td><strong>OMIM</strong></td><td>607440</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000125726</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P36776](https://www.uniprot.org/uniprot/P36776)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Mitochondrial Disorders</td></tr>
</table>
</div>

Overview

This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.

Function

LONP1 (Lon Peptidase 1, Mitochondrial) is a nuclear-encoded mitochondrial ATP-dependent protease essential for mitochondrial protein quality control. It degrades misfolded, oxidized, or damaged proteins and plays a crucial role in maintaining mitochondrial proteostasis. LONP1 also participates in the regulation of mitochondrial DNA (mtDNA) transcription and replication by degrading specific regulatory proteins.

In [neurons](/entities/neurons), LONP1 is critical for maintaining mitochondrial function, especially given the high energy demands and susceptibility to oxidative stress. Loss of LONP1 function leads to mitochondrial dysfunction, increased oxidative stress, and ultimately neuronal death—hallmarks of neurodegenerative diseases.

Expression

LONP1 is expressed in most tissues, with high expression in metabolically active tissues including brain, heart, and muscle. It is localized to the mitochondrial matrix. Its expression can be upregulated under conditions of mitochondrial stress.

Disease Associations

| Disease | Variants | Inheritance | Mechanism |
|---------|----------|-------------|-----------|
| Alzheimer's Disease | Altered expression | Acquired | Mitochondrial proteostasis failure |
| Parkinson's Disease | Altered expression | Acquired | Accumulation of damaged mitochondrial proteins |
| Mitochondrial Disorders | Various mutations | Maternal/Autosomal | Severe mitochondrial dysfunction |

Therapeutic Implications

• LONP1 activators as potential neuroprotective agents
• Mitochondrial-targeted antioxidants to reduce proteotoxic stress
• Gene therapy to enhance LONP1 expression in neurons

Key Publications

See Also

• [HTRA2](/genes/htra2) - Another mitochondrial protease
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Proteostasis](/mechanisms/proteostasis)
• [Oxidative Stress](/mechanisms/oxidative-stress)

External Links

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/) - Gene database
• [UniProt](https://www.uniprot.org/) - Protein database

References

Mitochondrial LON Protease Structure

Domain Architecture

LONP1 (Lon Peptidase 1, Mitochondrial) is a nuclear-encoded, ATP-dependent protease localized to the mitochondrial matrix. The protein consists of several functional domains[@van2002]:

• N-terminal substrate-binding domain: Recognizes and unfolds misfolded proteins
• ATPase domain: Provides energy for protein unfolding and translocation
• Proteolytic domain: Contains the catalytic serine residue for proteolysis
• Mitochondrial targeting sequence: N-terminal signal for mitochondrial import

Structural Mechanism

The LON protease functions as a hexameric ring structure:

Each subunit contributes to:

Cellular Functions

Protein Quality Control

LONP1 is the primary mitochondrial protease for misfolded protein clearance[@tatsuta2006]:

| Function | Mechanism | Importance |
|----------|-----------|------------|
| Degradation of misfolded proteins | Direct proteolysis | Prevents aggregation |
| Removal of oxidized proteins | Recognition of oxidative modifications | Protects against proteotoxic stress |
| Turnover of regulatory proteins | Controlled degradation | Regulates mitochondrial function |
| mtDNA maintenance | Degradation of TFAM and other factors | Controls mtDNA transcription |

Mitochondrial DNA Regulation

Beyond protein quality control, LONP1 regulates mitochondrial DNA[@tatsuta2006]:

• TFAM degradation: Controls mitochondrial transcription factor A levels
• mtDNA packaging: Regulates nucleoid structure and function
• Transcription control: Modulates mitochondrial gene expression
• Replication regulation: Influences mtDNA replication timing

Mitochondrial Dysfunction in Neurodegeneration

Alzheimer's Disease

LONP1 dysfunction contributes to AD pathogenesis through[@ngo2013]:

Parkinson's Disease

In PD, LONP1 plays critical roles in[@ngo2013]:

• α-Synuclein clearance: Mitochondrial autophagy defects allow protein accumulation
• Mitochondrial quality control: LONP1 loss exacerbates mitochondrial dysfunction
• Dopaminergic neuron vulnerability: Energy deficits lead to cell death
• PINK1/Parkin pathway: Links to mitophagy regulation

Common Mechanisms

| Mechanism | AD | PD |
|-----------|----|----|
| Protein aggregation | Aβ, tau | α-synuclein |
| Bioenergetic failure | ↓ATP | ↓ATP |
| Oxidative stress | ↑ROS | ↑ROS |
| Autophagy impairment | ↓Clearance | ↓Clearance |

Therapeutic Targeting

Pharmacological Approaches

| Strategy | Compound | Mechanism |
|----------|----------|-----------|
| LONP1 activators | TBD | Enhance protease activity |
| Antioxidants | CoQ10, MitoQ | Reduce oxidative stress |
| Mitochondrial biogenesis | PGC-1α agonists | Increase healthy mitochondria |
| Autophagy inducers | Trehalose, rapamycin | Enhance protein clearance |

Gene Therapy

• LONP1 overexpression: Increase mitochondrial protease capacity
• Mutant allele silencing: Reduce dominant-negative effects
• Mitochondrial targeting: Direct gene products to mitochondria
• Combination approaches: Synergize with autophagy enhancement

See Also

Pathway Diagram

The following diagram shows the key molecular relationships involving LONP1 discovered through SciDEX knowledge graph analysis: